This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.35% per year. These returns cover a period from January 1, 1988 through December 2, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Research Frontiers (REFR) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Research Frontiers (REFR) delivered earnings and revenue surprises of -100.00% and -28.00%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Research Frontiers (REFR) Q3 Earnings Preview: What to Look Out For
by Zacks Equity Research
Research Frontiers (REFR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Research Frontiers (REFR) is a Great Momentum Stock
by Zacks Equity Research
Does Research Frontiers (REFR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Has Research Frontiers (REFR) Outpaced Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Is (REFR) Outperforming Other Computer and Technology Stocks This Year?
Has Research Frontiers (REFR) Outpaced Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Is (REFR) Outperforming Other Computer and Technology Stocks This Year?
Why Look for Bargain Hunting? Bet on 5 Stocks with Rising P/E
by Zacks Equity Research
Cross the age-old barrier of low P/E investing, bet on these five stocks that boast rising P/E.
Use Rising P/E Tactic to Find Out 5 Winning Stocks
by Zacks Equity Research
Cross the age-old barrier of low P/E investing, bet on these five stocks that boast a rising P/E.
Zacks.com featured highlights: Edgewell Personal Care, Cambrex, Humana, Research Frontiers and Galena Biopharma
by Zacks Equity Research
Zacks.com featured highlights: Edgewell Personal Care, Cambrex, Humana, Research Frontiers and Galena Biopharma